Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 clinical trial evaluating paclitaxel in patients with recurrent or persistent ovarian cancer or primary peritoneal cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | Status: COMPLETED